trial · primary record
TUB-040
Ovarian Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 334 |
| Primary completion | 2027-12 |
| Primary endpoint | Phase 1: Percentage of Participants Experiencing any Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT06303505 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:46.792Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06303505
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.